387245009: Dinoprostone (substance)

SNOMED CT Concept\Substance\...

\A grouper concept for substances that are used in medicinal products for medical treatment, and also psychoactive substances that have few or no legitimate medical uses or that are not legally available to the person using them.\Eicosanoid (substance)\Prostanoid (substance)\Prostaglandin\Prostaglandin group E\Dinoprostone (substance)
\A grouper concept for substances that are used in medicinal products for medical treatment, and also psychoactive substances that have few or no legitimate medical uses or that are not legally available to the person using them.\Oxytocic agent (substance)\Dinoprostone (substance)

\Substance categorised by structure\Chemical\Chemical categorized by structure (substance)\Organic compound\...

\Organic acid and/or organic acid derivative\Carboxylic acid and/or carboxylic acid derivative (substance)\Carboxylic acid\Fatty acid\Unesterified fatty acid\Unsaturated fatty acid\Eicosanoid (substance)\Prostanoid (substance)\Prostaglandin\Prostaglandin group E\Dinoprostone (substance)

\Lipid\Fatty acid\Unesterified fatty acid\Unsaturated fatty acid\Eicosanoid (substance)\Prostanoid (substance)\Prostaglandin\Prostaglandin group E\Dinoprostone (substance)

\Biological substance\Eicosanoid (substance)\Prostanoid (substance)\Prostaglandin\Prostaglandin group E\Dinoprostone (substance)

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2003. Module: SNOMED CT core

Descriptions:

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Dinoprostone (substance)	Is a	Prostaglandin PGF>2< alpha	false	Inferred relationship	Some
Dinoprostone (substance)	Is a	Prostaglandin F2 alpha	false	Inferred relationship	Some
Dinoprostone (substance)	Is a	Oxytocic agent (substance)	true	Inferred relationship	Some
Dinoprostone (substance)	Is a	Prostaglandin E2	false	Inferred relationship	Some
Dinoprostone (substance)	Is a	Prostaglandin group E	true	Inferred relationship	Some

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Dinoprostone adverse reaction	Causative agent (attribute)	True	Dinoprostone (substance)	Inferred relationship	Some	1
Allergy to dinoprostone	Causative agent (attribute)	False	Dinoprostone (substance)	Inferred relationship	Some
Dinoprostone 10mg suppository	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Dinoprostone (substance)	Inferred relationship	Some
Dinoprostone 500 microgram oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Dinoprostone (substance)	Inferred relationship	Some
dinoprostone 1 mg/mL, ampoule de 0,75 mL de concentré pour perfusion	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Dinoprostone (substance)	Inferred relationship	Some
dinoprostone 10 mg/mL, ampoule de 0,5 mL de concentré pour perfusion	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Dinoprostone (substance)	Inferred relationship	Some
dinoprostone 10 mg/mL, ampoule de 0,5 mL de concentré avec diluant pour injection	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Dinoprostone (substance)	Inferred relationship	Some
Dinoprostone 400 microgram/mL vaginal gel	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Dinoprostone (substance)	Inferred relationship	Some
Product containing precisely dinoprostone 800 microgram/1 milliliter conventional release vaginal gel (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Dinoprostone (substance)	Inferred relationship	Some
Dinoprostone 3 mg vaginal tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Dinoprostone (substance)	Inferred relationship	Some
Product containing dinoprostone in oral dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Dinoprostone (substance)	Inferred relationship	Some	1
Product containing dinoprostone in parenteral dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Dinoprostone (substance)	Inferred relationship	Some	1
Dinoprostone-containing product in vaginal dose form	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Dinoprostone (substance)	Inferred relationship	Some	1
Dinoprostone 10mg insert	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Dinoprostone (substance)	Inferred relationship	Some
Product containing dinoprostone (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Dinoprostone (substance)	Inferred relationship	Some	1
Prostaglandin PGE2 measurement (procedure)	Component	True	Dinoprostone (substance)	Inferred relationship	Some	1
Cervical ripening with Prostaglandin E2	Direct substance	False	Dinoprostone (substance)	Inferred relationship	Some	1
Cervical ripening with Prostaglandin E2	Direct substance	True	Dinoprostone (substance)	Inferred relationship	Some	1
Allergy to dinoprostone	Causative agent (attribute)	True	Dinoprostone (substance)	Inferred relationship	Some	1
Dinoprostone 500 microgram oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Dinoprostone (substance)	Inferred relationship	Some	1
Dinoprostone 500 microgram oral tablet	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Dinoprostone (substance)	Inferred relationship	Some	1
Dinoprostone 3 mg vaginal tablet	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Dinoprostone (substance)	Inferred relationship	Some	1
Dinoprostone 3 mg vaginal tablet	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Dinoprostone (substance)	Inferred relationship	Some	1
Dinoprostone 500 microgram oral tablet	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Dinoprostone (substance)	Inferred relationship	Some	1
Product containing precisely dinoprostone 5 milligram/0.5 milliliter conventional release solution for infusion ampule	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	False	Dinoprostone (substance)	Inferred relationship	Some	1
Product containing precisely dinoprostone 5 milligram/0.5 milliliter conventional release solution for infusion ampule	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	False	Dinoprostone (substance)	Inferred relationship	Some	1
Dinoprostone 400 microgram/mL vaginal gel	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Dinoprostone (substance)	Inferred relationship	Some	1
Dinoprostone 400 microgram/mL vaginal gel	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Dinoprostone (substance)	Inferred relationship	Some	1
Product containing precisely dinoprostone 800 microgram/1 milliliter conventional release vaginal gel (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Dinoprostone (substance)	Inferred relationship	Some	1
Product containing precisely dinoprostone 800 microgram/1 milliliter conventional release vaginal gel (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Dinoprostone (substance)	Inferred relationship	Some	1
Product containing precisely dinoprostone 750 microgram/0.75 milliliter conventional release solution for infusion ampule	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	False	Dinoprostone (substance)	Inferred relationship	Some	1
Product containing precisely dinoprostone 750 microgram/0.75 milliliter conventional release solution for infusion ampule	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	False	Dinoprostone (substance)	Inferred relationship	Some	1
Dinoprostone only product	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Dinoprostone (substance)	Inferred relationship	Some	1
Dinoprostone only product in parenteral dose form	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Dinoprostone (substance)	Inferred relationship	Some	1
Product containing only dinoprostone in oral dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Dinoprostone (substance)	Inferred relationship	Some	1
Dinoprostone only product in vaginal dose form	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Dinoprostone (substance)	Inferred relationship	Some	1
Dinoprostone 1 mg/mL solution for infusion	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Dinoprostone (substance)	Inferred relationship	Some	1
Dinoprostone 1 mg/mL solution for infusion	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Dinoprostone (substance)	Inferred relationship	Some	1
Dinoprostone 10 mg/mL solution for infusion	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Dinoprostone (substance)	Inferred relationship	Some	1
Dinoprostone 10 mg/mL solution for infusion	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Dinoprostone (substance)	Inferred relationship	Some	1
Dinoprostone 10 mg prolonged-release vaginal pessary	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Dinoprostone (substance)	Inferred relationship	Some	1
Dinoprostone 10 mg prolonged-release vaginal pessary	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Dinoprostone (substance)	Inferred relationship	Some	1
Dinoprostone 10 mg/mL solution for injection	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Dinoprostone (substance)	Inferred relationship	Some	1
Dinoprostone 10 mg/mL solution for injection	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Dinoprostone (substance)	Inferred relationship	Some	1
Dinoprostone 1 mg/mL solution for injection	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Dinoprostone (substance)	Inferred relationship	Some	1
Dinoprostone 1 mg/mL solution for injection	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Dinoprostone (substance)	Inferred relationship	Some	1
Product containing precisely dinoprostone 1 milligram/1 milliliter conventional release solution for infusion and/or injection (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Dinoprostone (substance)	Inferred relationship	Some	1
Product containing precisely dinoprostone 1 milligram/1 milliliter conventional release solution for infusion and/or injection (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Dinoprostone (substance)	Inferred relationship	Some	1
Dinoprostone 10 mg/mL solution for infusion and/or injection	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Dinoprostone (substance)	Inferred relationship	Some	1
Dinoprostone 10 mg/mL solution for infusion and/or injection	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Dinoprostone (substance)	Inferred relationship	Some	1
Dinoprostone 10 mg prolonged-release vaginal delivery system	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Dinoprostone (substance)	Inferred relationship	Some	1
Dinoprostone 10 mg prolonged-release vaginal delivery system	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Dinoprostone (substance)	Inferred relationship	Some	1

This concept is not in any reference sets

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
1763818011	Dinoprostone (substance)	en	Fully specified name	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
1776056016	Dinoprostone	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
2672787011	Prostaglandin E2	en	Synonym (core metadata concept)	Active	Only initial character case insensitive (core metadata concept)	SNOMED CT core
4944860018	Prostaglandin PGE2	en	Synonym (core metadata concept)	Active	Only initial character case insensitive (core metadata concept)	SNOMED CT core
50741000195114	dinoprostone	it	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT Switzerland NRC maintained Module
806421000172111	dinoprostone	fr	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT Switzerland NRC maintained Module
64831000195114	Dinoproston	de	Synonym (core metadata concept)	Active	Entire term case sensitive (core metadata concept)	SNOMED CT Switzerland NRC maintained Module
235841000195118	Prostaglandin E2	de	Synonym (core metadata concept)	Active	Entire term case sensitive (core metadata concept)	SNOMED CT Switzerland NRC maintained Module
579631000274116	PGE2 - Prostaglandin E2	de	Synonym (core metadata concept)	Active	Entire term case sensitive (core metadata concept)	SNOMED CT Switzerland NRC maintained Module